CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Backstrom Jay T. Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2026-06-13 | Owen Adams Catherine Director | Option exercise | +1,976 | 8,049 | ||
| 2026-06-13 | Owen Adams Catherine Director | Option exercise · Restricted stock units | −1,976 | 0 | ||
| 2026-06-13 | CAPELLO JEFFREY D Director | Option exercise | +1,976 | 8,049 | ||
| 2026-06-13 | CAPELLO JEFFREY D Director | Option exercise · Restricted stock units | −1,976 | 0 | ||
| 2026-04-02 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +8,500 | 52,586 | ||
| 2026-04-02 | Burns James William Chief Legal Officer | Sale 10b5-1 | −3,280 | $34.71 | $114K | 49,306 |
| 2026-04-02 | Burns James William Chief Legal Officer | Option exercise · Performance share units 10b5-1 | −8,500 | 8,500 | ||
| 2026-04-02 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +8,500 | 83,217 | ||
| 2026-04-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −2,940 | $34.71 | $102K | 80,277 |
| 2026-04-02 | Gheuens Sarah Chief Medical Officer | Option exercise · Performance share units 10b5-1 | −8,500 | 8,500 | ||
| 2026-04-02 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +8,500 | 58,139 | ||
| 2026-04-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −3,141 | $34.71 | $109K | 54,998 |
| 2026-04-02 | Jones Cecilia Chief Financial Officer | Option exercise · Performance share units 10b5-1 | −8,500 | 8,500 | ||
| 2026-04-02 | Milanova Tsveta Chief Commercial Officer | Option exercise 10b5-1 | +8,500 | 50,091 | ||
| 2026-04-02 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −3,262 | $34.71 | $113K | 46,829 |
| 2026-04-02 | Milanova Tsveta Chief Commercial Officer | Option exercise · Performance share units 10b5-1 | −8,500 | 8,500 | ||
| 2026-04-02 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Option exercise 10b5-1 | +8,100 | 13,241 | ||
| 2026-04-02 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Sale 10b5-1 | −2,959 | $34.71 | $103K | 10,282 |
| 2026-04-02 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Option exercise · Performance share units 10b5-1 | −8,100 | 8,100 |
Page 4 of 48 · 941 trades